Status:
COMPLETED
Health Care Decisions for Female Adolescents: The Role of Mothers and Daughters in Decision Making
Lead Sponsor:
University of Louisville
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Cervical Cancer
Eligibility:
FEMALE
13+ years
Brief Summary
Preventing cervical cancer is a public health concern. Since 2006 a quadrivalent vaccine for young women nine to twenty six years of age has been available to protect against the human papillomavirus ...
Detailed Description
Preventing cervical cancer is a public health concern. Since 2006 a quadrivalent vaccine for young women nine to twenty six years of age has been available to protect against the human papillomavirus ...
Eligibility Criteria
Inclusion
- Adolescent females 13-17 years of age
- and adolescent's mother, any age
- and adolescent not pregnant
- and adolescent has not received vaccine for HPV
Exclusion
- Males
- daughters younger than 13 yrs of age
- daughters older than 17 yrs of age
- pregnant daughters
- daughters who have received the HPV vaccine
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT00807898
Start Date
January 1 2009
End Date
January 1 2011
Last Update
May 5 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Louisville School of Nursing
Louisville, Kentucky, United States, 40292